WO2006030304A3 - Novel forms of fluvastatin sodium, processes for preparation and pharmaceutical compositions thereof - Google Patents
Novel forms of fluvastatin sodium, processes for preparation and pharmaceutical compositions thereof Download PDFInfo
- Publication number
- WO2006030304A3 WO2006030304A3 PCT/IB2005/002754 IB2005002754W WO2006030304A3 WO 2006030304 A3 WO2006030304 A3 WO 2006030304A3 IB 2005002754 W IB2005002754 W IB 2005002754W WO 2006030304 A3 WO2006030304 A3 WO 2006030304A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fluvastatin sodium
- processes
- pharmaceutical compositions
- preparation
- forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
Abstract
Applications Claiming Priority (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1766/DEL/2004 | 2004-09-17 | ||
IN1766DE2004 | 2004-09-17 | ||
IN1848DE2004 | 2004-09-27 | ||
IN1848/DEL/2004 | 2004-09-27 | ||
IN1956/DEL/2004 | 2004-10-11 | ||
IN1958DE2004 | 2004-10-11 | ||
IN1958/DEL/2004 | 2004-10-11 | ||
IN1956DE2004 | 2004-10-11 | ||
IN2168/DEL/2004 | 2004-10-29 | ||
IN2170DE2004 | 2004-10-29 | ||
IN2172/DEL/2004 | 2004-10-29 | ||
IN2170/DEL/2004 | 2004-10-29 | ||
IN2172DE2004 | 2004-10-29 | ||
IN2168DE2004 | 2004-10-29 | ||
IN428DE2005 | 2005-02-28 | ||
IN428/DEL/2005 | 2005-02-28 | ||
IN1703DE2005 | 2005-06-30 | ||
IN1703/DEL/2005 | 2005-06-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006030304A2 WO2006030304A2 (en) | 2006-03-23 |
WO2006030304A3 true WO2006030304A3 (en) | 2006-12-07 |
Family
ID=35427294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/002754 WO2006030304A2 (en) | 2004-09-17 | 2005-09-16 | Novel forms of fluvastatin sodium, processes for preparation and pharmaceutical compositions thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006030304A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1638937E (en) | 2003-06-18 | 2009-01-27 | Teva Pharma | Fluvastatin sodium crystal form xiv, processes for preparing it, compositions containing it and methods of using it |
EP1799641A4 (en) * | 2004-10-05 | 2007-09-19 | Biocon Ltd | Process for the preparation of amorphous fluvastatin sodium |
WO2006109147A1 (en) * | 2005-04-12 | 2006-10-19 | Glenmark Pharmaceuticals Limited | Substantially pure amorphous fluvastatin, processes for its preparation and pharmaceutical compositions containing same |
US20080027125A1 (en) * | 2006-02-27 | 2008-01-31 | Tamas Koltai | Fluvastatin sodium novel forms and preparation thereof |
CN100429202C (en) * | 2006-06-30 | 2008-10-29 | 浙江新东港药业股份有限公司 | Preparation method of amorphous fluvastatin sodium |
ES2321571B1 (en) * | 2007-07-18 | 2010-03-11 | Ercros Industrial, S.A. | SOLVATOS DE FLUVASTATINA SODICA AND ITS USE AS INTERMEDIATE IN OBTAINING FLUVASTATINA SODICA AMORFA. |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4739073A (en) * | 1983-11-04 | 1988-04-19 | Sandoz Pharmaceuticals Corp. | Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof |
US6124340A (en) * | 1996-06-24 | 2000-09-26 | Astra Aktiebolag | Polymorphic compounds |
US20030032666A1 (en) * | 2001-08-03 | 2003-02-13 | Van Der Schaaf Paul Adriaan | Crystalline forms |
WO2003018555A1 (en) * | 2001-08-22 | 2003-03-06 | Ciba Speciality Chemicals Holding Inc. | Process for the preparation of indole derivatives |
US20030166946A1 (en) * | 2000-05-26 | 2003-09-04 | Annemarie Wolleb | Process for the preparation of indole derivatives and intermediates of the process |
WO2004096765A2 (en) * | 2003-05-01 | 2004-11-11 | Morepen Laboratories Ltd. | A novel crystalline polymorph of fluvastatin sodium and a process for preparing it |
US20050032884A1 (en) * | 2003-06-18 | 2005-02-10 | Revital Lifshitz-Liron | Eluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
WO2005019170A1 (en) * | 2003-08-26 | 2005-03-03 | Biocon Limited | Novel process for preparation of 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1h-indol-2-yl]-3, 5-dihydroxy-6-heptenoic acid sodium salt |
WO2005037787A1 (en) * | 2003-10-16 | 2005-04-28 | Ciba Specialty Chemicals Holding Inc. | Crystalline form of fluvastatin sodium |
WO2005080332A1 (en) * | 2004-01-14 | 2005-09-01 | Cadila Healthcare Limited | Novel form of fluvastatin sodium |
US20050209259A1 (en) * | 2004-03-17 | 2005-09-22 | Le Huang | Novel anhydrous amorphous forms of rosuvastatin calcium, pitavastatin calcium and fluvastatin sodium |
-
2005
- 2005-09-16 WO PCT/IB2005/002754 patent/WO2006030304A2/en active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4739073A (en) * | 1983-11-04 | 1988-04-19 | Sandoz Pharmaceuticals Corp. | Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof |
US6124340A (en) * | 1996-06-24 | 2000-09-26 | Astra Aktiebolag | Polymorphic compounds |
US20030166946A1 (en) * | 2000-05-26 | 2003-09-04 | Annemarie Wolleb | Process for the preparation of indole derivatives and intermediates of the process |
US20030032666A1 (en) * | 2001-08-03 | 2003-02-13 | Van Der Schaaf Paul Adriaan | Crystalline forms |
WO2003018555A1 (en) * | 2001-08-22 | 2003-03-06 | Ciba Speciality Chemicals Holding Inc. | Process for the preparation of indole derivatives |
WO2004096765A2 (en) * | 2003-05-01 | 2004-11-11 | Morepen Laboratories Ltd. | A novel crystalline polymorph of fluvastatin sodium and a process for preparing it |
US20050032884A1 (en) * | 2003-06-18 | 2005-02-10 | Revital Lifshitz-Liron | Eluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
WO2005019170A1 (en) * | 2003-08-26 | 2005-03-03 | Biocon Limited | Novel process for preparation of 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1h-indol-2-yl]-3, 5-dihydroxy-6-heptenoic acid sodium salt |
WO2005037787A1 (en) * | 2003-10-16 | 2005-04-28 | Ciba Specialty Chemicals Holding Inc. | Crystalline form of fluvastatin sodium |
WO2005080332A1 (en) * | 2004-01-14 | 2005-09-01 | Cadila Healthcare Limited | Novel form of fluvastatin sodium |
US20050209259A1 (en) * | 2004-03-17 | 2005-09-22 | Le Huang | Novel anhydrous amorphous forms of rosuvastatin calcium, pitavastatin calcium and fluvastatin sodium |
Non-Patent Citations (2)
Title |
---|
O. REPIC, K. PRASAD, G.T. LEE: "The Story of Lescol: From Research to Production", ORGANIC PROCESS RESEARCH & DEVELOPMENT, vol. 5, 2001, pages 519 - 527, XP002357640 * |
TEMPKIN O ET AL: "Asymmetric Synthesis of 3,5-Dihydroxy-6(E)-heptenoate-containing HMG-CoA Reductase Inhibitors", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 53, no. 31, 4 August 1997 (1997-08-04), pages 10659 - 10670, XP004105948, ISSN: 0040-4020 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006030304A2 (en) | 2006-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006030304A3 (en) | Novel forms of fluvastatin sodium, processes for preparation and pharmaceutical compositions thereof | |
BRPI0713923B8 (en) | hydroxylated and methoxylated pyrimidyl cyclopentane compounds, pharmaceutical composition comprising said compounds, method of preparing a compound, and use thereof | |
WO2006113909A3 (en) | Humanized anti-cd70 binding agents and uses thereof | |
EA026235B1 (en) | Macrocyclic inhibitors of flaviviridae viruses | |
WO2007118205A3 (en) | Compounds, compositions and methods for treating hormone-dependent maladies | |
TNSN05306A1 (en) | Substituted pyrrole derivatives. | |
WO2005080352A3 (en) | Quinazoline derivatives and therapeutic use thereof | |
CA2602643A1 (en) | Composition for improving blood cholesterol levels | |
WO2006035277A3 (en) | Novel processes for preparing amorphous rosuvastatin calcium and a novel polymorphic form of rosuvastatin sodium | |
WO2006081431A3 (en) | Compounds for treating inflammatory and demyelinating diseases | |
WO2007078895A3 (en) | Modified release formulations of tramadol and uses thereof | |
BRPI0510719A (en) | naphthalimide derivatives, pharmaceutical composition, use and method of preparation thereof | |
WO2008008660A3 (en) | Cyclopentane derivatives as antiglaucoma agents | |
WO2008050199A3 (en) | Substituted phenylmethyl bicyclocarboxyamide compounds | |
WO2006127815A3 (en) | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists | |
WO2008008700A3 (en) | Substituted cyclopentane derivatives as therapeutic agents | |
WO2008060372A3 (en) | Thrombin receptor antagonists based on the modified tricyclic unit of himbacine | |
WO2004075840A3 (en) | Selective non-steroidal glucocorticoid receptor modulators | |
WO2006031782A3 (en) | Salvinorin derivatives as opioid receptor ligands | |
WO2006097768A3 (en) | Treatment of intestinal conditions by a compound which causes rna interference | |
WO2003007883A3 (en) | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents | |
WO2006040643A3 (en) | Polymorphic forms of efavirenz and processes for their preparation | |
WO2006029210A3 (en) | Acyclic 1,3-diamines and uses therefor | |
WO2007146856A3 (en) | Substituted gamma lactams as therapeutic agents | |
WO2004093789A3 (en) | Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |